Cargando…

Inflammation and Parkinson's Disease

Detalles Bibliográficos
Autores principales:	Barcia, Carlos, Hunot, Stéphane, Guillemin, Gilles J., Pitossi, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2011
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255314/ https://www.ncbi.nlm.nih.gov/pubmed/22254149 http://dx.doi.org/10.4061/2011/729054

Ejemplares similares

The Involvement of Neuroinflammation and Kynurenine Pathway in Parkinson's Disease
por: Zinger, Anna, et al.
Publicado: (2011)

El posible rol de la inflamación en las secuelas neurológicas del COVID-19
por: Pitossi, Fernando
Publicado: (2021)

Glial-Mediated Inflammation Underlying Parkinsonism
por: Barcia, Carlos
Publicado: (2013)

Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson’s Disease?
por: Leal, María C., et al.
Publicado: (2013)

Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease
por: Godoy, María Clara Pott, et al.
Publicado: (2008)

Cannabidiol in Parkinson’s disease
por: Rieder, Carlos R.
Publicado: (2020)

The Degenerating Substantia Nigra as a Susceptible Region for Gene Transfer-Mediated Inflammation
por: Roca, Valeria, et al.
Publicado: (2011)

Qué son las células madre
por: Pitossi, Fernando Juan
Publicado: (2015)

DAP12 and CD11b contribute to the microglial-induced death of dopaminergic neurons in vitro but not in vivo in the MPTP mouse model of Parkinson’s disease
por: Kinugawa, Kiyoka, et al.
Publicado: (2013)

Familial Parkinson's Disease/Parkinsonism
por: Tomiyama, Hiroyuki, et al.
Publicado: (2015)

Editorial: Glial Cells: Managers of Neuro-Immunity
por: Barcia, Carlos, et al.
Publicado: (2016)

Introductory Editorial
por: Guillemin, Gilles J.
Publicado: (2008)

ISTRY 2013 Special Issue
por: Guillemin, Gilles J.
Publicado: (2013)

The Pesticide Chlordecone Promotes Parkinsonism-like Neurodegeneration with Tau Lesions in Midbrain Cultures and C. elegans Worms
por: Parrales-Macias, Valeria, et al.
Publicado: (2023)

Dietary Supplements/Antioxidants: Impact on Redox Status in Brain Diseases
por: Guillemin, Gilles J., et al.
Publicado: (2017)

People with Parkinson’s as Partners for the Journal of Parkinson’s Disease
por: McFarthing, Kevin, et al.
Publicado: (2023)

Mitochondria and Parkinson's Disease
por: Simon, David K., et al.
Publicado: (2011)

Rehabilitation and Parkinson's Disease
por: Earhart, Gammon M., et al.
Publicado: (2012)

Neuropsychiatry of Parkinson's Disease
por: Teixeira, Antonio L., et al.
Publicado: (2012)

Gait in Parkinson's Disease
por: Martinez-Ramirez, Daniel, et al.
Publicado: (2019)

Neurobiology of Parkinson’s Disease
por: Morelli, Micaela, et al.
Publicado: (2023)

Banking on iPSC- Is it Doable and is it Worthwhile
por: Solomon, Susan, et al.
Publicado: (2014)

e-Cadherin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson Disease
por: Cataldi, Samuela, et al.
Publicado: (2016)

Immunology and the Central Nervous System
por: Barcia, Carlos, et al.
Publicado: (2013)

Epidemiology of Parkinsonism and Parkinson's disease in Sub-Saharan Africa: Nigerian profile
por: Akinyemi, Rufus O
Publicado: (2012)

Nonmotor Symptoms of Parkinson's Disease
por: Rektorova, Irena, et al.
Publicado: (2011)

Communication Impairments in Parkinson's Disease
por: Murdoch, Bruce, et al.
Publicado: (2011)

Animal Models of Parkinson's Disease
por: Imai, Yuzuru, et al.
Publicado: (2011)

Implication of Autophagy in Parkinson's Disease
por: González-Polo, Rosa Ana, et al.
Publicado: (2013)

Rehabilitation and Parkinson's Disease 2013
por: Earhart, Gammon M., et al.
Publicado: (2013)

Dyskinesia in Parkinson's Disease Therapy
por: Carta, Anna Rosa, et al.
Publicado: (2012)

Sleep Problems in Parkinson's Disease
por: Hirata, Koichi, et al.
Publicado: (2015)

The sweet road to Parkinson’s disease
por: Renaud, Justine, et al.
Publicado: (2019)

Nonmotor Symptoms of Parkinson's Disease
por: Wu, Shey-Lin, et al.
Publicado: (2017)

Intracerebroventricular dopamine for Parkinson's disease
por: Devos, David, et al.
Publicado: (2017)

Parkinson’s Disease: We Care!
por: Bloem, Bastiaan R., et al.
Publicado: (2020)

Neurobiology Research in Parkinson’s Disease
por: Yasuhara, Takao
Publicado: (2020)

Advances in Parkinson’s Disease Drugs
por: Di Stefano, Antonio, et al.
Publicado: (2021)

Optimizing Treatment of Parkinson’s Disease
por: Nyholm, Dag, et al.
Publicado: (2022)

Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
por: Santaella, Anna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hi2al4ahtei8c514mjru8723hn